Products
Latest News
FAQ
|
Search
Search
Filters
Clear All
Study Phase
Early Phase 1
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
Phase 4
Not Applicable
Recruitment Status
Recruiting
Not yet recruiting
Active, not recruiting
Completed
Suspended
Terminated
Withdrawn
Study Type
Interventional
Observational
Expanded Access
Others
Eligibility Sex
All
Female
Male
Healthy Volunteers
All
Include
Exclude
Found
1
clinical trials
|
View Analysis
Sort by:
Tumor Treating Fields for Locally Advanced NSCLC
Phase 1
Recruiting
Conditions
Non Small Cell Lung Cancer
Interventions
Device: NovoTTF-200T (TTFields) System
Radiation: carboplatin chemotherapy
Drug: Durvalumab
Subscribe
First Posted Date
2023-11-09
Last Posted Date
2024-10-07
Lead Sponsor
University of Utah
Target Recruit Count
30
Registration Number
NCT06124118
Locations
🇺🇸
Huntsman Cancer Institute, Salt Lake City, Utah, United States
Subscribe
Prev
1
Next
© Copyright 2025. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy